URINE AMPHETAMINE DIRECT RIA KIT (I-125)— 510(k) K913866

Name: FDA 510(k) clearance K913866
Creator: U.S. Food and Drug Administration
Published: 1991-09-25

Substantially Equivalent

Immunalysis Corporation

FDA 510(k) clearance K913866 for URINE AMPHETAMINE DIRECT RIA KIT (I-125), Substantially Equivalent on 1991-09-25. Applicant: Immunalysis Corporation. Device class: 2.

Clearance details

Applicant: Immunalysis Corporation
Product code: Code DJP
Device class: Class 2
Regulation: 21 CFR 862.3100
Advisory panel: Clinical Toxicology
Date received: 1991-08-27
Decision date: 1991-09-25
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Glendale, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code DJP

view all

K960526 — PRIMIDONE EIA TEST1996-03-18
K912755 — ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE1991-08-26
K882228 — REVISED DOUBLE ANTIBODY AMPHETAMINE1988-08-08
K881817 — ABUSCREEN(R) ONTRAK(TM) FOR AMPHETAMINES1988-07-29
K854009 — ABUSCREEN RADIOIMMUNOASSAY FOR AMPHETAMINE-HIGH SP1985-10-15

More clearances from Immunalysis Corporation

view all

K252520 — SEFRIA Hydrocodone Oral Fluid2025-09-11
K232898 — Quantisal Oral Fluid Collection Device2023-11-21
K223781 — Quantisal II Oral Fluid Collection Device2023-07-28
K203564 — SEFRIA Oxycodone Oral Fluid Enzyme Immunoassay2021-12-22
K203647 — SEFRIA Methamphetamine Oral Fluid Enzyme Immunoassay2021-12-22

Data sourced from openFDA. This site is unofficial and independent of the FDA.